United Kingdom · Question · Written question
UIN 1507
Tixagevimab/cilgavimab
Original
Introduced
13 May 2022
Last action
7 June 2022 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
7 June 2022
Summary
To ask the Secretary of State for Health and Social Care, what plans his Department has to make Evusheld available to immunocompromised people.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
13 May 2022
Written question
To ask the Secretary of State for Health and Social Care, what plans his Department has to make Evusheld available to immunocompromised people.
Source: Commons
7 June 2022
Answer
Evusheld has been granted conditional marketing approval by the Medicines and Healthcare products Regulatory Agency (MHRA) on 17 March 2022. However, the MHRA highlighted uncertainty over the appropriate dose needed for protection against the Omicron vari...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2022-05-13/1507
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1462825
- uk · wq-1462825 · source updated 7 June 2022